相关实验视频

Updated: Jun 24, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

开发COVID-19疫苗的创新和挑战,以实现更安全的明天

Devika S Kumar¹, Krishna Prasanth², Ashni Bhandari²

¹Research, Panimalar Medical College Hospital and Research Institute, Chennai, IND.

|June 10, 2024

概括

本综述研究了SARS-CoV-2变种的演变及其对疫苗疗效的影响. 它探讨了开发下一代COVID-19疫苗的创新策略,以对抗病毒突变.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
公共卫生公共卫生

背景情况:

疫苗接种是公共卫生的基石,SARS-CoV的教训为COVID-19疫苗开发提供了信息.
目前的mRNA疫苗显示出有效性,但新出现的SARS-CoV-2变种由于传播能力和严重性增加而带来了挑战.
紧迫性,对病毒的初步理解有限,以及需要安全,可扩展的解决方案,使COVID-19疫苗开发复杂化.

研究的目的:

审查SARS-CoV-2的进化轨迹及其对疫苗有效性的影响.
确定和讨论开发下一代COVID-19疫苗的新策略.
为导航病毒进化和增强未来疫苗设计提供见解.

主要方法:

文献综述侧重于SARS-CoV-2的进化和突变模式.
分析快速疫苗开发和制造所面临的挑战.
探索各种疫苗开发方法,包括基于结构的,基于T细胞的,粘膜的和纳米技术.

主要成果:

新出现的SARS-CoV-2变种具有可以逃避现有的疫苗诱导免疫力的突变.
疫苗的持续适应是必要的,以解决病毒遗传的变异性.
制造业扩大规模需要严格的质量控制来满足全球需求.

结论:

了解SARS-CoV-2的演变对于开发针对当前和未来变种的有效疫苗至关重要.
基于结构的设计,基于T细胞的疫苗,粘膜免疫和纳米技术等创新方法为改善疫苗开发提供了有希望的途径.
本综述提供了一份战略路线图,以应对病毒进化在疫苗开发中所带来的挑战.

关键词:

接种Covid-19疫苗的人群突变挑战疫苗的突变纳米技术是纳米技术.尖蛋白质挑战的挑战各种策略,各种策略.

更多相关视频

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...